BD 256088 - Veritor System Rapid Antigen Test Kit SARS-CoV-2 & Influenza A/B Detection, Anterior Nasal Swab Sample, 30 PER/BX

BD 256088 - Veritor System Rapid Antigen Test Kit SARS-CoV-2 & Influenza A/B Detection, Anterior Nasal Swab Sample, 30 PER/BX

The BD 256088 Veritor System Rapid Antigen Test Kit is a dual-target diagnostic assay designed to detect SARS-CoV-2, Influenza A, and Influenza B from a clinician-collected anterior nasal swab. Built for use with the BD Veritor Plus Analyzer, this multiplex immunoassay provides fast, objective, and digital results, enabling clinicians to differentiate between COVID-19 and influenza infections in minutes. Each kit includes all necessary components for sample collection, processing, and analyzer-based test interpretation, supporting efficient point-of-care respiratory disease diagnostics.

Key Benefits

This rapid respiratory panel provides simultaneous detection of three common pathogens, allowing quicker clinical decisions and targeted treatment. Analyzer-interpreted results eliminate human reading errors and ensure high accuracy. The anterior nasal swab collection method offers improved patient comfort compared with nasopharyngeal sampling. The rapid turnaround time supports timely triage, reduced patient wait times, and more appropriate use of antiviral therapies or isolation measures.

Compatibility and Applications

The BD 256088 test kit is compatible with:

• BD Veritor Plus Analyzer
• Clinician-collected anterior nasal swabs
• CLIA-waived and moderate-complexity testing environments

This test is commonly used in:

• Clinics and urgent care centers
• Emergency departments and outpatient facilities
• Pharmacies and retail health clinics
• School, workplace, and community respiratory screening programs
• Long-term care and senior health facilities

Usage Guidelines

Collect an anterior nasal swab specimen per clinical guidelines. Insert the swab into the reagent tube, mix thoroughly, and apply the treated specimen to the test device. After the appropriate reaction time, insert the test device into the BD Veritor Plus Analyzer for automated reading. Follow all instructions in the kits package insert and observe required biosafety procedures. Dispose of all used materials in designated biohazard containers.

Certifications, Safety Standards, and Regulatory Approvals

The BD SARS-CoV-2/Flu A+B rapid test is authorized under FDA Emergency Use Authorization (EUA) for point-of-care testing using the Veritor Plus Analyzer. It meets applicable CE and IVD regulatory standards and is manufactured in ISO 9001 and ISO 13485 certified facilities. Each lot undergoes extensive quality control to ensure assay accuracy, reagent stability, and reliable performance.

Comparison with Competitor Products

Compared with single-pathogen rapid tests, the BD multiplex format detects SARS-CoV-2, Influenza A, and Influenza B simultaneously, reducing the need for multiple nasal swabs or separate tests. Many competitor tests rely on manual interpretation, increasing potential for reading inconsistencies. BDs analyzer-driven digital results provide superior reliability, ease of use, and consistency across high-volume testing environments.

Typical User Profile and Application Scenarios

This test kit is most commonly used by:

• Point-of-care clinicians managing acute respiratory cases
• Healthcare professionals in urgent care and ambulatory settings
• Long-term care staff needing rapid outbreak control
• Pharmacists and retail clinic providers offering respiratory testing
• Occupational health teams monitoring workplace illness

Best Practices for Use and Maintenance

Store the test components within the temperature range specified by the manufacturer. Use the BD Veritor Plus Analyzer exclusively for result interpretation. Do not mix reagents or components from different kit lots. Perform routine quality control in accordance with facility and CLIA requirements. Maintain strict infection-control practices during sample collection and disposal.

Regulatory and Safety Information

For in vitro diagnostic use only. Authorized under FDA EUA for SARS-CoV-2 and influenza antigen detection. Not for at-home use. Single-use components only. Handle all biological samples as potentially infectious and follow OSHA and facility biosafety standards.

How to Order

To order the BD 256088 Veritor System SARS-CoV-2/Flu A+B Rapid Antigen Test Kit, add the item to your cart and complete checkout through CIA Medicals secure ordering system. For bulk orders, supply programs, or technical support, contact CIA Medical customer service at (312) 275-5850 or submit an inquiry through the form on this page.